目的探讨万拉法新与氯米帕明治疗焦虑抑郁障碍共病的疗效及安全性。
Objective To explore the curative effects and safety of venlafaxine and clomipramine in anxiety and depression comorbidity.
结论万拉法新治疗焦虑抑郁障碍共病疗效与氯米帕明相当，但起效时间较氯米帕明快，且安全性高，依从性好。
Conclusion Venlafaxine has equivalent curative effect to clomipramine in the treatment of anxiety and depression comorbidity, takes effect faster, and has higher safety and better compliance.
目的：了解老年期痴呆患者抑郁和焦虑障碍共病率及其相关因素。
Objective: to understand the comorbidity rate of depression and anxiety in the elderly dementia and the related factors.
应用推荐